| Document |
Document Title |
|
WO/2017/162413A1 |
The invention relates to solid, at least triple-phase active substance preparations, in which two separate phases are embedded in a multiparticulate manner into a coherent active substance and antioxidant-free phase, one of said embedded...
|
|
WO/2017/142854A1 |
A method of producing positively charged liposome vesicles for use as carriers of lipophilic molecules. A mixture of hydrogenated phospholipids, a cationic excipient and a lipophilic molecule are dissolved in a solvent to form a composit...
|
|
WO/2017/125379A1 |
The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds by using of at least one alkali hydroxide and/or earth alkali hydroxide, to specific formulations and to the use of such specif...
|
|
WO/2017/111761A1 |
The present invention relates to a process for producing carotenoid extract from a carotenoid source, the process comprising: providing a carotenoid source; providing an extraction solvent including at least one acetal compound and at le...
|
|
WO/2017/100915A1 |
There is provided an improved extraction process for obtaining integral & active thylakoid membranes that have longer shelf-life at room temperature. Particularly, the extract is lyophilized in a solution of PVP and remains stable with a...
|
|
WO/2017/099443A1 |
The present invention relates to a retinoid compound containing dopamine and a method for preparing the same and, more specifically, to a retinoid compound containing dopamine which can bind dopamine to retinoic acid so as to improve the...
|
|
WO/2017/099662A1 |
A method for producing derivatives of N-retinoylaminoalkane sulfonic acid, the method comprising providing retinoic acid, chloroformate, aminoalkanesulfonic acid selected from the group consisting of cysteic acidand alkyl ester thereof, ...
|
|
WO/2017/084493A1 |
Disclosed is a method for removing benzo[α]pyrene from a liposoluble natural extract. The method of the present invention comprises adding a suitable solvent to a crude natural extract product so as to obtain a mixed material; heating t...
|
|
WO/2017/083351A1 |
Non-naturally occurring microorganisms are provided that produce taurine and/or taurine precursors, e.g., hypotaurine, sulfoacetaldehyde, or cysteate, utilizing exogenously added enzyme activities. Methods of producing taurine and/or tau...
|
|
WO/2017/075698A1 |
There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment...
|
|
WO/2017/049110A1 |
Compounds having inhibitory activity against retinaldehyde dehydrogenases (RALDHs). The compounds can be used, for example, to inhibit synthesis of retinoic acid for the treatment of refractive error disorders such as myopia, and as infe...
|
|
WO/2017/029313A1 |
The present invention relates to a process for preparing 1-(2,6,6-trimethylcyclohex-2- en-1-yl)but-2-en-1-one, which comprises a) providing 6,10-dimethylundeca-1,5,9-trien-4-ol, b) oxidizing 6,10-dimethylundeca-1,5,9-trien-4-ol provided ...
|
|
WO/2017/019556A1 |
Embodiments of the present disclosure generally relate to compositions, methods and systems for the isolation and separation of undesirable products from desirable products in biomass extracts. In certain embodiments, the present disclos...
|
|
WO/2016/207199A1 |
The present invention is directed to a process for the manufacture of a formulation of β-carotene, wherein the β-carotene is embedded in a matrix of at least one modified food starch, and wherein the β-carotene in said formulation has...
|
|
WO/2016/202125A1 |
Disclosed are an intermediate, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-forma
midine]phenyl-2-propenamide (II), applicable in preparing AZD9291 (I) and a preparation method for the intermediate. Preparation steps comprise: ...
|
|
WO/2016/181288A1 |
The retinoid X receptors (RXRs) are ligand-activated transcription factors heterodimerize with a number of nuclear hormone receptors, thereby controlling a variety of physiological processes. The invention relates to novel enantiomer com...
|
|
WO/2016/175670A1 |
The present invention discloses a process of isolation and purification of diatoxanthin and diadinoxanthin, which consists of five steps including: diatoms cultivation, pigment extraction, pigment partitioning, silica gel alkalization, o...
|
|
WO/2016/146802A1 |
The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. Astaxanthin compositions, which contain at least 80 wt.%, in particular at least 90 wt.%, especially at least 95 wt.%...
|
|
WO/2016/146804A1 |
The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particul...
|
|
WO/2016/124783A1 |
The invention relates to a microcapsule comprising at least one active substance selected from lutein and lutein esters embedded in a matrix comprising porcine gelatine or bovine gelatine and optionally one or more other matrix component...
|
|
WO/2016/124784A1 |
The invention relates to microcapsules comprising at least one active substance selected from lutein and lutein esters embedded in a matrix comprising gum acacia and optionally one or more other matrix components, wherein the content of ...
|
|
WO/2016/079103A1 |
The present invention relates to a process for the preparation of 1-(2,6,6- trimethylcyclohexyl)-alkan-3-ols, in particular 1-(2,6,6-trimethylcyclohexyl)-hexan-3-ol. The invention further relates to 5-alkoxy-1-(2,6,6-trimethylcyclohexeny...
|
|
WO/2016/076454A1 |
The present invention relates to a method for producing 9-cis β-carotene from microorganisms, comprising a method for improving the culture rate of microorganisms using a photochemical gas generated by the micro-spray of gas and the con...
|
|
WO/2016/063278A1 |
The present disclosure provides a polymer having a repeating unit comprising at least one astaxanthin moiety, including processes for its preparation and various uses thereof.
|
|
WO/2016/059151A1 |
The present invention relates to a catalytic process for the ethynylation of specific poly- unsaturated aldehydes and ketones.
|
|
WO/2016/059150A1 |
The present invention relates to a new method to produce 7,8-dihydro-C15- aldehyde.
|
|
WO/2016/050909A1 |
The present invention relates to a process for purifying the xanthophylls astaxanthin and canthaxanthin. The process comprises suspending the xanthophyll in an organic solvent or solvent mixture, treating the suspension of the xanthophyl...
|
|
WO/2016/047532A1 |
A compound represented by formula (IV) or a salt thereof has an inhibitory effect on abscisic acid receptors. The compound or a salt thereof can be used as a plant growth regulator. [X is an ethylene group, an ethenylene group or an ethy...
|
|
WO/2016/037785A1 |
The invention relates to an environmentally friendly, resource-conserving, and economical method for producing astaxanthin esters of formula 1, wherein astaxanthin of formula 2 is doubly esterified with fatty acid chlorides of general fo...
|
|
WO/2016/023772A1 |
The invention relates to a process for preparing a cyclic alpha-keto alcohol, especially a 6-hydroxycyclohexenone of the formula 1a or 1b, from a cyclic alpha-keto enol, especially a 6-hydroxycyclohexadienone of the formula 2a or 2b, usi...
|
|
WO/2016/023732A1 |
The invention relates to a method for the non-stereoselective and for the stereoselective synthesis of astaxanthin from astacin. For this purpose, a reductant is used, which is selected from the group of hydrogen gas, a secondary alcohol...
|
|
WO/2015/178404A1 |
The present invention addresses the problem of discovering a carotenoid compound exhibiting excellent water solubility. Provided is a carotenoid derivative represented by general formula (I) [in general formula (I): X represents a carbon...
|
|
WO/2015/175479A1 |
This invention relates to pharmaceutical compositions for oral administration to treat, for example, acute radiation sickness, wherein the composition comprises, for example, a first agent which is selected from the group consisting of b...
|
|
WO/2015/144831A1 |
The present invention relates to an improved process for isolating a carotenoid from a carotenoid-producing bioorganism, as well as to a formulation comprising such a carotenoid, and the use of such a solid formulation in feed products (...
|
|
WO/2015/109657A1 |
The present invention provides a method for manufacturing nature zeaxanthin by means of in-situ concentration. Specifically, the method comprises: preparing nature zeaxanthin from a plant by using extraction and saponification , performi...
|
|
WO/2015/067711A1 |
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where methanol is used to drastically reduce the content of dichloromethane in suc...
|
|
WO/2015/067705A1 |
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where methanol is used to drastically reduce the content of dichloromethane in suc...
|
|
WO/2015/067706A1 |
The present invention is directed to a process for the manufacture of synthetic food-grade astaxanthin with a content of dichloromethane ≤ 250 ppm comprising the following steps: a) Providing synthetic astaxanthin crystals containing d...
|
|
WO/2015/067707A1 |
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where ethyl acetate is used to drastically reduce the content of dichloromethane a...
|
|
WO/2015/067709A1 |
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where an alkanol selected from the group consisting of methanol, ethanol, 1-propan...
|
|
WO/2015/059696A1 |
The invention provides a process for the preparation of alkyl 4-methyl-6-(2,6,6-trimethylcyclohex-lenyl) hex-3-enoate comprising a single step wherein 2-methyl-4-(2,6,6- trimethylcyclohex-l-en-l-yl)butanal is reacted with monoalkyl malon...
|
|
WO/2015/043112A1 |
A high-content carotenoid compound from adonis amurensis. The content of the total carotenoid of the carotenoid compound is higher than 95%. The content of all-trans (3S, 3'S)-carotenoid is higher than 80%. The carotenoid crystals have a...
|
|
WO/2015/028132A1 |
An aqueous emulsion for use in veterinary medicine which contains beta carotene and can be administered parenterally from a sterile multi-dose container contains acetylcysteine in an amount of between 1 and 8 wt.-% as a substance which s...
|
|
WO/2015/009174A1 |
The invention relates to an oxidation process for producing astaxanthin from meso-zeaxanthin using o-iodoxybenzoic acid as an oxidant.
|
|
WO/2014/202677A1 |
The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds by using at least one alkali and/or earth alkali metal salt of an organic acid, to specific formulations and to the use of such...
|
|
WO/2014/170225A1 |
The present invention relates to oily astaxanthin (AXT) suspensions with an improved profile of properties, obtainable by grinding AXT particles in an oil suitable as food or feed additive; the use of the oily AXT suspension prepared in ...
|
|
WO/2014/129974A1 |
Described herein is a material for reversibly binding to a carotenoid comprising a support coupled to silver ions in an amount to enable reversible binding with carotenoids, and wherein with the exception of silver ions, is substantially...
|
|
WO/2014/083067A1 |
The present invention relates to a process for the production of discrete solid extruded particles comprising dispersion droplets, to such particles as well as to the use of such particles in food, feed, pharmaceutical and personal care ...
|
|
WO/2014/045561A1 |
The present invention addresses the problems of providing an anticancer drug comprising a carotenoid and of providing a novel carotenoid and an antioxidant comprising the novel carotenoid. The above problems are solved by the discovery t...
|
|
WO/2014/023917A1 |
The invention relates to a method for preparing a composition rich in lutein produced by microalgae, particularly microalgae belonging to the Chlorella genus, more specifically produced by Chlorella vulgaris, characterized in that said m...
|
